Oncogenic role of c-Myb was documented by c-myb knockdown in estrogen receptor (ER)-positive breast cancer cell lines resulting in block of estrogen-dependent proliferation [58] and TGFβ-induced invasiveness in vitro [28]. Here, ESR1 is linked to breast carcinoma.